Related Experiment Videos
["Micrometastases": the pathologist's point of view]
J M Guinebretière1, G Contesso
1Département de pathologie, Institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif. guinbret@igr.fr
Bulletin Du Cancer
|July 19, 2001
Summary
Detecting micrometastases, small cancer spread, requires advanced pathology techniques like serial slicing and immunohistochemistry. Standardized definitions and further research are crucial for understanding their prognostic value and biological properties.
Area of Science:
- Oncology
- Pathology
- Cancer Biology
Context:
- Cancer screening advances detect smaller tumors and less lymph node/organ dissemination.
- Pathologists use serial slicing and immunohistochemistry to detect micrometastases.
- Current detection rates vary, and the prognostic value of micrometastases remains uncertain.
Purpose:
- To review current methods for micrometastasis detection.
- To highlight disparities in detection rates and prognostic value.
- To emphasize the need for standardized terminology and further research into micrometastasis biology.
Summary:
- Micrometastases detection relies on serial slicing and immunohistochemistry, achieving high rates in sentinel nodes.
- The International Union Against Cancer (UICC) defines micrometastasis as <= 2 mm.
- The new pTNM classification categorizes micrometastases as 'isolated tumor cells' or 'micrometastasis' based on location, requiring further prognostic analysis.
Impact:
- Standardized terminology and definitions are essential for comparative analysis.
- Further research is needed to establish the prognostic value of different micrometastasis categories.
- Understanding the biological properties driving distant dissemination is a key future challenge.